Average cost of drugs for extensively drug-resistant tuberculosis in Kyrgyzstan
Kyrgyzstan: Average cost of drugs for extensively drug-resistant tuberculosis was 4,786 constant 2022 US$ in 2022. ▼ Falling
Latest (2022)
4,786 constant 2022 US$
Change on year
up 40.9%
World rank
11th
of 56 countries
All-time high
5,949 constant 2022 US$
in 2017
All-time low
3,143 constant 2022 US$
in 2019
Years of data
6
2017–2022
Average cost of drugs for extensively drug-resistant tuberculosis in Kyrgyzstan, 2017–2022
Source: WHO (2025) – with minor processing by Our World in Data. Measured in constant 2022 US$.
Analysis
In 2022, average cost of drugs for extensively drug-resistant tuberculosis in Kyrgyzstan stood at 4,786 constant 2022 US$.
That represents a change of up 40.9% on the previous year and down 19.5% over ten years.
Kyrgyzstan ranks 11th of 56 countries on this measure, in the top quarter.
Average cost of drugs for extensively drug-resistant tuberculosis in Kyrgyzstan, year by year
| Year | constant 2022 US$ | Change |
|---|---|---|
| 2017 | 5,949 constant 2022 US$ | — |
| 2018 | 4,552 constant 2022 US$ | -23.5% |
| 2019 | 3,143 constant 2022 US$ | -31.0% |
| 2020 | 3,143 constant 2022 US$ | +0.0% |
| 2021 | 3,397 constant 2022 US$ | +8.1% |
| 2022 | 4,786 constant 2022 US$ | +40.9% |
Kyrgyzstan compared with similar countries
- Kyrgyzstan's 4,786 constant 2022 US$ is above the median for lower middle income countries, which is 1,525 constant 2022 US$, 3.1× the median. (24 countries reporting)
- Kyrgyzstan's 4,786 constant 2022 US$ is above the median for Europe & Central Asia, which is 4,345 constant 2022 US$, 1.1× the median. (8 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 4,548 constant 2022 US$ | 3,143 constant 2022 US$ | 5,949 constant 2022 US$ | 3 |
| 2020s | 3,775 constant 2022 US$ | 3,143 constant 2022 US$ | 4,786 constant 2022 US$ | 3 |
Countries ranked near Kyrgyzstan
More reference data data for Kyrgyzstan
- Emission Totals - Indirect emissions (N2O) - Manure applied to Soils 0.2833 (2050)
- Emission Totals - Indirect emissions (N2O) - Manure left on Pasture 0.6193 (2050)
- Emission Totals - Indirect emissions (N2O) - IPCC Agriculture 1.24 (2050)
- Emission Totals - Indirect emissions (N2O) - Crop Residues 0.0857 (2050)
- Emission Totals - Indirect emissions (N2O) - Agricultural Soils 1.24 (2050)
- Emission Totals - Emissions (N2O) - Manure applied to Soils 0.95 (2050)
- Emission Totals - Emissions (N2O) - Manure Management 0.8535 (2050)
- Emission Totals - Emissions (N2O) - Manure left on Pasture 2.51 (2050)
- Emission Totals - Emissions (N2O) - IPCC Agriculture 5.84 (2050)
- Emission Totals - Emissions (N2O) - Crop Residues 0.4667 (2050)
Frequently asked questions
- What is average cost of drugs for extensively drug-resistant tuberculosis in Kyrgyzstan?
- Average cost of drugs for extensively drug-resistant tuberculosis in Kyrgyzstan was 4,786 constant 2022 US$ in 2022, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest average cost of drugs for extensively drug-resistant tuberculosis recorded in Kyrgyzstan?
- The highest recorded value was 5,949 constant 2022 US$ in 2017.
- What is the lowest average cost of drugs for extensively drug-resistant tuberculosis recorded in Kyrgyzstan?
- The lowest recorded value was 3,143 constant 2022 US$ in 2019.
- How does Kyrgyzstan rank for average cost of drugs for extensively drug-resistant tuberculosis?
- Kyrgyzstan ranks 11th out of 56 countries with data for 2022.
- Is average cost of drugs for extensively drug-resistant tuberculosis rising or falling in Kyrgyzstan?
- Over the last ten years it is down 19.5%. The long-run trend across the full record is falling.
- Where does this Kyrgyzstan data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Average cost of drugs for extensively drug-resistant tuberculosis. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Average cost of drugs spent per patient starting extensively drug-resistant tuberculosis treatment, excluding buffer stock.